Implantable Cardioverter-Defibrillators

  • David Korpas


An implantable cardioverter defibrillator (ICD) is an active implantable medical device primarily used to deliver a high-energy electric shock to the heart via intracardial leads. The electric shock causes concurrent depolarization of all cell membranes in myocardial volume followed by an absolute refractory period. As a result, a tachycardia impulse spreading in the myocardium is interrupted. This implantable device also works as a pacemaker and applies antitachycardia pacing (ATP) to terminate ventricular tachycardia (VT) when high-energy shocks are not required.




  1. 70.
    Teligen 100 system guide. Boston Scientific, St. Paul. © 2009, 283 pGoogle Scholar
  2. 71.
    Bernstein A, Camm AJ, Fletcher RD et al (1993) North American society of pacing and electrophysiology policy statement. The NASPE/BPEG defibrillator code. Pacing Clin Electrophysiol 16(9):1776–1780PubMedCrossRefGoogle Scholar
  3. 72.
    International Organization for Standardization (2010) ISO 14708-6:2010: Implants for surgery – active implantable medical devices – part 6: particular requirements for active implantable medical devices intended to treat tachyarrhythmia (including implantable defibrillators), 25 Feb 2010Google Scholar
  4. 73.
    Strydis Ch. Implantable microelectronic devices. M.Sc thesis. Accessed 6 Jan 2011
  5. 74.
    Medtronic Corporation: Maximo DR 7278 – Implant manual. Accessed 30 Sept 2010
  6. 75.
    See Reference [66]Google Scholar
  7. 76.
    Theuns DAMJ, Rivero-Ayerza M, Goedhart MD, Miltenburg M, Jordaens JL (2008) Morphology discrimination in implantable cardioverter-defibrillators: consistency of template match percentage during atrial tachyarrhythmias at different heart rates. Europace 10:1060–1066PubMedCrossRefGoogle Scholar
  8. 77.
    Medtronic Corporation: Protecta CRT-D D364TRG – Clinician manual (EE). Accessed 24 Nov 2010
  9. 78.
    Mocanu D et al (2004) Patient-specific computational analysis of transvenous defibrillation: a comparison to clinical metrics in humans. Ann Biomed Eng 32(6):775–783PubMedCrossRefGoogle Scholar
  10. 79.
    Jacob S et al (2010) High defibrillation threshold: the science, signs and solutions. Indian Pacing Electrophysiol J 10(1):21–39PubMedGoogle Scholar
  11. 82.
    System guide Cognis 100-D CRT-D. Boston Scientific, St. Paul, © 2009, 306 pGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • David Korpas
    • 1
    • 2
  1. 1.Boston Scientific Czech RepublicPragueCzech Republic
  2. 2.Faculty of Electrical Engineering and Computer Science Department of Cybernetics and Biomedical EngineeringVSB - Technical University of OstravaOstrava-PorubaCzech Republic

Personalised recommendations